Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - topiramate - oral tablet - 25mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - topiramate - oral tablet - 25mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - topiramate - oral tablet - 25mg

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 70 mg (equivalent: sumatriptan, qty 50 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; lactose; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide red - imigran tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran tablets in the treatment of basilar or hemiplegic migraines.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 140 mg (equivalent: sumatriptan, qty 100 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose - sumatriptan (imigran) tablets and injection are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran in the treatment of basilar or hemiplegic migraine.

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - topiramate - oral tablet - 25mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - topiramate - oral tablet - 25mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - topiramate - oral tablet - 25mg